SuperworthSonoma Pharmaceuticals market cap SNOA
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $5.3M
- Highest close in our data
- $42.9M
- Sep 2011
Sonoma Pharmaceuticals is worth $5.3M at the close on Oct 23, 2026, at $1.11 a share.
That is down 16% over the last year and down 56% over five years.
Its highest close in our data was $42.9M in Sep 2011.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $5.3M | $1.9M | $6.9M | −13% |
| 2025 | $6.1M | $3.2M | $8.8M | +67% |
| 2024 | $3.7M | $2.1M | $7M | +49% |
| 2023 | $2.5M | $722.6K | $7M | −29% |
| 2022 | $3.5M | $3.4M | $14.2M | −75% |
| 2021 | $14.1M | $11.2M | $18.9M | −5% |
| 2020 | $14.8M | $5.6M | $18.6M | +153% |
| 2019 | $5.9M | $4.7M | $12M | +30% |
| 2018 | $4.5M | $4.4M | $24M | −81% |
| 2017 | $23.6M | $18.4M | $33.7M | +11% |
| 2016 | $21.2M | $14.8M | $21.6M | +12% |
| 2015 | $18.9M | $6.8M | $24.2M | +46% |
| 2014 | $12.9M | $12.3M | $35.6M | −45% |
| 2013 | $23.3M | $14.6M | $31.9M | +3% |
| 2012 | $22.6M | $19.9M | $39.5M | −20% |
| 2011 | $28.2M | $28.2M | $42.9M | n/a |
Against its peers
Companies in Healthcare nearest Sonoma Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| SNOASonoma Pharmaceuticals | $5.3M |
| OXBROXBRIDGE RE HOLDINGS | $7.7M |
| EDUCEducational Development | $8.7M |
| GTIMGood Times Restaurants | $13.6M |
| MDRRMedalist Diversified | $15.4M |
| BCGBinah Capital | $18.2M |
| VIPVulcan Infrastructure & Power | $19.6M |
| MXCMexco Energy | $20.5M |
| CKXCKX Lands | $21.5M |
| MSGMMotorsport Games | $22.5M |
| ATCHAtlasClear | $24M |
| Peer median | $18.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Sonoma Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.